Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
11-valent pneumococcal conjugate vaccine effectiveness study in Philippine infants
ISRCTN62323832Phase 3Completed
- Sponsor
- ARIVAC Consortium
- Start
- Jul 2000
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Pneumococcal pneumonia (PP), invasive pneumococcal disease (IPD), pneumococcal septicemia and 1 more comparing 11PCV vaccine group with Placebo control group (2 arms). Started Jul 2000; status: completed.
02
Drugs
eleven-valent pneumococcal tetanus-diphtheria toxoid conjugate vaccine
03
Conditions
Pneumococcal pneumonia (PP)invasive pneumococcal disease (IPD)pneumococcal septicemiapneumococcal meningitis
Beyond the preview
Go deeper on ISRCTN62323832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN62323832.